CN101797314A - Medicinal composition for treating adolescent myopia and preparation method thereof - Google Patents
Medicinal composition for treating adolescent myopia and preparation method thereof Download PDFInfo
- Publication number
- CN101797314A CN101797314A CN 201010152532 CN201010152532A CN101797314A CN 101797314 A CN101797314 A CN 101797314A CN 201010152532 CN201010152532 CN 201010152532 CN 201010152532 A CN201010152532 A CN 201010152532A CN 101797314 A CN101797314 A CN 101797314A
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- fructus
- adolescent myopia
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicinal composition for treating adolescent myopia, which is prepared from the following raw materials: barbary wolfberry fruit, south dodder seed, largehead atractylodes rhizome, oriental waterplantain rhizome, spina date seed, common selfheal fruit-spike, platycodon root, chrysanthemum, Chinese angelica, liquoric root, Chinese magnoliavine fruit and glossy privet fruit. The invention also relates to a preparation method for the medicinal composition. The medicinal composition of the invention is prepared from the pure traditional Chinese medicines, adopts a traditional preparation method, reserves the medicinal properties of the medicaments, has exact curative effect and can effectively treat adolescent myopia.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition for the treatment of adolescent myopia and preparation method thereof.
Background technology
Myopia is a kind of commonly encountered diseases, frequently-occurring disease, and it can only be seen and closely can not see far.This eye after the dioptric system refractive power of directional light through having a look at that comes from unlimited distance, assembled focus before retina when rest, then form unclear picture on retina, and distant vision obviously reduces, but near vision is still normal.This disease generally just forms in the teenager stage.In recent years, in China students in middle and primary schools, bathomorphic sickness rate increases year by year.Only according to the statistics in 92 years of State Education Commission, students in middle and primary schools' myopia rate is 74.78% up to 49.47%, ten adolescent myopia rate below eight years old, and is the trend that rises year by year, has a strong impact on student's physical and mental health.
The bathomorphic method of treatment is a lot of at present, and for example therapies such as vision correction instrument, Micropole glasses, laser therapy, magnetic therapy, electrotherapy, acupuncture are generally.Although various therapies all have certain curative effect, be eased to a certain extent, most of curative effects are not consolidated.Current still do not have a kind of method preferably to bathomorphic treatment.Glasses for the myopia are worn in being still of generally adopting in the society now.Though wearing glasses for the myopia can correct defects of vision, regulate diopter, but to the no therapeutical effect of eyes itself, and it is big more to wear its number of degrees more, can not stop the development of myopia, the current medical worker who presses for medical technical field is for the Hope Project of motherland keeps punching, solve prevention, treatment, the consolidation of vast adolescent myopia oculopathy as early as possible, problems such as thorough radical cure.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of adolescent myopia.
The present invention also aims to provide the preparation of drug combination method of this treatment adolescent myopia.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of adolescent myopia, it is made by weight by following bulk drugs:
1～5 part of 1～10 part of Rhizoma Atractylodis Macrocephalae of 1～10 part of Semen Cuscutae of Fructus Lycii
1～5 part of 1～10 part of Spica Prunellae of 1～5 part of Semen Ziziphi Spinosae of Rhizoma Alismatis
1～10 part of 1～10 part of Radix Angelicae Sinensis of 1～5 part of Flos Chrysanthemi of Radix Platycodonis
1～10 part of 1～10 part of Fructus Ligustri Lucidi of 1～10 part of Fructus Schisandrae Chinensis of Radix Glycyrrhizae.
Preferably, it is made by weight by following bulk drugs:
3 parts of 10 parts of Rhizoma Atractylodis Macrocephalaes of 10 parts of Semen Cuscutae of Fructus Lycii
5 parts of 10 parts of Spica Prunellaes of 3 parts of Semen Ziziphi Spinosaes of Rhizoma Alismatis
5 parts of 10 parts of Radix Angelicae Sinensis of 5 parts of Flos Chrysanthemis of Radix Platycodonis
10 parts of 10 parts of Fructus Ligustri Lucidi of 5 parts of Fructus Schisandrae Chinensis of Radix Glycyrrhizae.
The present invention also provides a kind of preparation of drug combination method for the treatment of adolescent myopia, and this method comprises:
1) gets Fructus Lycii 100 grams, Semen Cuscutae 100 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Alismatis 30 grams, Semen Ziziphi Spinosae 100 grams, Spica Prunellae 50 grams, Radix Platycodonis 50 grams, Flos Chrysanthemi 100 grams, Radix Angelicae Sinensis 50 grams, Radix Glycyrrhizae 50 grams, Fructus Schisandrae Chinensis 100 grams, Fructus Ligustri Lucidi 100 grams, place 2000 ml waters, 100 ℃ of following reflux 2 hours, filter, obtain filtering residue and filtrate;
2) filtrate in the described step 1) is concentrated into 500 milliliters, promptly.
Pharmaceutical composition of the present invention is prepared with pure Chinese medicine, adopts traditional manufacture method, has kept the property of medicine of medicine, and curative effect is clear and definite, can treat adolescent myopia effectively.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Fructus Lycii 100 grams, Semen Cuscutae 100 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Alismatis 30 grams, Semen Ziziphi Spinosae 100 grams, Spica Prunellae 50 grams, Radix Platycodonis 50 grams, Flos Chrysanthemi 100 grams, Radix Angelicae Sinensis 50 grams, Radix Glycyrrhizae 50 grams, Fructus Schisandrae Chinensis 100 grams, Fructus Ligustri Lucidi 100 grams, place 2000 ml waters, 100 ℃ of following reflux 2 hours, filter, obtain filtering residue and filtrate.Described filtrate is concentrated into 500 milliliters, promptly.
Experimental example
Physical data:
Adolescent myopia 50 examples, male's 25 examples wherein, women's 25 examples.Patient's naked vision is lower than 4.8 (standard logarithmic visual acuity chart lamp SLD-II-types); Get rid of organic disease through slit lamp, ophthalmofundoscopy, be diagnosed as myopia.And the definition of true, the pseudomyopia that meets that Society of Ophthalmology of Chinese Medical Association dioptrics of eye group in 1985 works out and criteria for classification (referring to " modern ophthalmology handbook, Beijing, People's Health Publisher,, 563-564 page or leaf in 1993).At random it is divided into treatment group and matched group.25 examples are organized in treatment, age 8-18 year, average 13.5 years old, course of disease February-6 year; Matched group 25 examples, age 8-18 year, average 14 years old, course of disease February-6 year.Two groups of cases are learned the processing there was no significant difference by statistics at aspects such as age, the course of disease and clinical manifestation, myopic degrees.
Therapeutic scheme
Treatment group: the decoction that uses preparation among the embodiment 1.Take each 20 milliliters every day 2 times.One month is 1 course of treatment.
Matched group: use Tropicamide collyrium (available from Guangzhou strong psychological treatment industry company limited), drip 4 before sleeping every night, one month is 1 course of treatment.
Criterion of therapeutical effect
Produce effects: vision improves 〉=2 row; Effectively: vision improves 〉=1 row＜2 row; Invalid: vision does not have obvious raising less than 1 row or the descender arranged.
Treat the result after a course of treatment:
Treatment group: produce effects 15 examples, effective 10 examples, total effective rate 100%.
Matched group: produce effects 0 example, effective 15 examples, invalid 10 examples, total effective rate 60%.
Untoward reaction:
The treatment group is not observed tangible untoward reaction.
There are 5 routine patients the untoward reaction of many tears, dizziness to occur in the matched group.
Claims (3)
1. pharmaceutical composition for the treatment of adolescent myopia is characterized in that it is made by weight by following bulk drugs:
1～5 part of 1～10 part of Rhizoma Atractylodis Macrocephalae of 1～10 part of Semen Cuscutae of Fructus Lycii
1～5 part of 1～10 part of Spica Prunellae of 1～5 part of Semen Ziziphi Spinosae of Rhizoma Alismatis
1～10 part of 1～10 part of Radix Angelicae Sinensis of 1～5 part of Flos Chrysanthemi of Radix Platycodonis
1～10 part of 1～10 part of Fructus Ligustri Lucidi of 1～10 part of Fructus Schisandrae Chinensis of Radix Glycyrrhizae.
2. the pharmaceutical composition of treatment adolescent myopia according to claim 1 is characterized in that, it is made by weight by following bulk drugs:
3 parts of 10 parts of Rhizoma Atractylodis Macrocephalaes of 10 parts of Semen Cuscutae of Fructus Lycii
5 parts of 10 parts of Spica Prunellaes of 3 parts of Semen Ziziphi Spinosaes of Rhizoma Alismatis
5 parts of 10 parts of Radix Angelicae Sinensis of 5 parts of Flos Chrysanthemis of Radix Platycodonis
10 parts of 10 parts of Fructus Ligustri Lucidi of 5 parts of Fructus Schisandrae Chinensis of Radix Glycyrrhizae.
3. preparation of drug combination method for the treatment of adolescent myopia, this method comprises the following steps:
1) gets Fructus Lycii 100 grams, Semen Cuscutae 100 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Alismatis 30 grams, Semen Ziziphi Spinosae 100 grams, Spica Prunellae 50 grams, Radix Platycodonis 50 grams, Flos Chrysanthemi 100 grams, Radix Angelicae Sinensis 50 grams, Radix Glycyrrhizae 50 grams, Fructus Schisandrae Chinensis 100 grams, Fructus Ligustri Lucidi 100 grams, place 2000 ml waters, 100 ℃ of following reflux 2 hours, filter, obtain filtering residue and filtrate;
2) filtrate in the described step 1) is concentrated into 500 milliliters, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101525329A CN101797314B (en) | 2010-04-22 | 2010-04-22 | Medicinal composition for treating adolescent myopia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101525329A CN101797314B (en) | 2010-04-22 | 2010-04-22 | Medicinal composition for treating adolescent myopia and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101797314A true CN101797314A (en) | 2010-08-11 |
| CN101797314B CN101797314B (en) | 2011-11-16 |
Family
ID=42593255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101525329A Expired - Fee Related CN101797314B (en) | 2010-04-22 | 2010-04-22 | Medicinal composition for treating adolescent myopia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101797314B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104116900A (en) * | 2014-08-07 | 2014-10-29 | 赵西迷 | Traditional Chinese medicine dressing for preventing and treating myopia and preparation method of traditional Chinese medicine dressing |
| CN105288053A (en) * | 2015-12-02 | 2016-02-03 | 北京林业大学 | Woods Chinese herbal medicine recipe for preventing and treating children shortsightedness and preparation method of recipe |
| CN107789452A (en) * | 2016-08-29 | 2018-03-13 | 黑龙江德能理疗技术开发有限责任公司 | One kind prevents and treats near-sighted oral liquid and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109786A (en) * | 1994-09-01 | 1995-10-11 | 徐永 | Method of manufacturing eyesight-improving bag for navel treatment |
| CN1660226A (en) * | 2004-12-29 | 2005-08-31 | 王四旺 | 'Wuzi Mingmu' pill and preparing technique |
| CN1745829A (en) * | 2005-09-29 | 2006-03-15 | 李广中 | Zijing stomach tonifying pill |
| CN101279008A (en) * | 2007-04-05 | 2008-10-08 | 北京华恒汉方医药科技有限公司 | Chinese medicine pad pasting for preventing and controlling myopic eye, eyestrain symptoms and eyebase ischemia |
-
2010
- 2010-04-22 CN CN2010101525329A patent/CN101797314B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109786A (en) * | 1994-09-01 | 1995-10-11 | 徐永 | Method of manufacturing eyesight-improving bag for navel treatment |
| CN1660226A (en) * | 2004-12-29 | 2005-08-31 | 王四旺 | 'Wuzi Mingmu' pill and preparing technique |
| CN1745829A (en) * | 2005-09-29 | 2006-03-15 | 李广中 | Zijing stomach tonifying pill |
| CN101279008A (en) * | 2007-04-05 | 2008-10-08 | 北京华恒汉方医药科技有限公司 | Chinese medicine pad pasting for preventing and controlling myopic eye, eyestrain symptoms and eyebase ischemia |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104116900A (en) * | 2014-08-07 | 2014-10-29 | 赵西迷 | Traditional Chinese medicine dressing for preventing and treating myopia and preparation method of traditional Chinese medicine dressing |
| CN104116900B (en) * | 2014-08-07 | 2017-11-03 | 赵西迷 | A kind of herbal application for preventing and treating myopia and preparation method thereof |
| CN105288053A (en) * | 2015-12-02 | 2016-02-03 | 北京林业大学 | Woods Chinese herbal medicine recipe for preventing and treating children shortsightedness and preparation method of recipe |
| CN107789452A (en) * | 2016-08-29 | 2018-03-13 | 黑龙江德能理疗技术开发有限责任公司 | One kind prevents and treats near-sighted oral liquid and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101797314B (en) | 2011-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101601828B (en) | Eyesight-recovering traditional Chinese medicine for treating optic neuritis and optic nerve atrophy | |
| CN105326803A (en) | Difenidol hydrochloride tablets for treating motion sickness and preparation method thereof | |
| CN101797314B (en) | Medicinal composition for treating adolescent myopia and preparation method thereof | |
| CN104971304A (en) | Xerophthalmia treatment medicine | |
| CN107753554A (en) | A kind of prepared slices of Chinese crude drugs for eyeshield | |
| CN101647913B (en) | Traditional Chinese medicine preparation for treating senile cataract and viral keratitis | |
| CN102240357B (en) | Medicament for treating tinnitus and preparation method thereof | |
| CN107029037A (en) | It is a kind of to improve the eyesight-improving health care function patch of eyes based on nitric oxide principle | |
| CN107929356B (en) | Eye drop and preparation method and application thereof | |
| CN101417054B (en) | Traditional Chinese medicine composite for treating dizziness | |
| CN107669912A (en) | A kind of rehabilitation of vision oral liquid | |
| CN110339314A (en) | A kind of eyesight patch and preparation method thereof | |
| CN103877376A (en) | Pharmaceutical preparation for treating depression | |
| CN107412539A (en) | Prevent and treat the herbal application of myopia | |
| CN103191387B (en) | Medicament for treating juvenile myopia | |
| CN103550357B (en) | A kind of control muscae volitantes collyrium and its production and use | |
| CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
| CN107773691A (en) | A kind of Chinese medicine for treating insomnia | |
| CN1073600A (en) | The preparation method of the Chinese medicine preparation of treatment pseudomyopia | |
| CN106177598A (en) | A kind of manufacture method of the refined even buccal tablet being of value to treating diabetes | |
| CN104873668A (en) | Traditional Chinese medicine composition for treating optic atrophy | |
| CN103961491A (en) | Traditional Chinese medicine for treating amblyopia | |
| CN103550276A (en) | Applications of herba taraxaci in preparing medicaments | |
| CN104056068A (en) | Traditional Chinese medicine eye drops for treating chronic conjunctivitis | |
| CN104274710A (en) | Traditional Chinese medicine for treating hypertensive vertigo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111116 Termination date: 20120422 |